Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/radiogenomics-a-valuable-tool-for-the-clinical-assessment-and-research-CLrW52bI4b
References (143)
-
H. Fujita (2020)
AI-based computer-aided diagnosis (AI-CAD): the latest review to read firstRadiological Physics and Technology, 13
-
G. Chornokur, E. Amankwah, J. Schildkraut, C. Phelan (2013)
Global ovarian cancer health disparities.Gynecologic oncology, 129 1
-
Liang Zhou, Yinghui Wang, Meijuan Zhou, Ying Zhang, Pengfei Wang, Xiaoxing Li, Jing Yang, Hongmei Wang, Zhenhua Ding (2018)
HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma developmentNature Communications, 9
-
A. Koff, F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, James Roberts (1991)
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene familyCell, 66
-
E. Kuhn, Tian-Li Wang, Kai Doberstein, A. Bahadirli-Talbott, A. Ayhan, A. Sehdev, R. Drapkin, R. Kurman, I. Shih (2016)
CCNE1 Amplification and Centrosome Number Abnormality in Serous Tubal Intraepithelial Carcinoma- Further Evidence Supporting its Role as a Precursor of Ovarian High-Grade Serous CarcinomaModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 29
-
K. Clark, Bruce Vendt, Kirk Smith, J. Freymann, J. Kirby, P. Koppel, S. Moore, Stanley Phillips, David Maffitt, Michael Pringle, Lawrence Tarbox, F. Prior (2013)
The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information RepositoryJournal of Digital Imaging, 26
-
M. Schaner, D. Ross, G. Ciaravino, T. Sørlie, O. Troyanskaya, M. Diehn, Yan Wang, G. Duran, Thomas Sikic, S. Caldeira, H. Skomedal, I. Tu, T. Hernandez-Boussard, Steven Johnson, P. O'dwyer, M. Fero, G. Kristensen, A. Børresen-Dale, T. Hastie, R. Tibshirani, M. Rijn, N. Teng, T. Longacre, D. Botstein, P. Brown, B. Sikic (2003)
Gene expression patterns in ovarian carcinomas.Molecular biology of the cell, 14 11
-
D. Tan, C. Rothermundt, K. Thomas, E. Bancroft, R. Eeles, S. Shanley, A. Ardern-jones, A. Norman, S. Kaye, M. Gore (2008)
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 34
-
Guillaume Thibault, J. Angulo, F. Meyer (2014)
Advanced Statistical Matrices for Texture Characterization: Application to Cell ClassificationIEEE Transactions on Biomedical Engineering, 61
-
E. Segal, C. Sirlin, C. Ooi, A. Adler, J. Gollub, Xin Chen, Bryan Chan, G. Matcuk, Christopher Barry, Howard Chang, M. Kuo (2007)
Decoding global gene expression programs in liver cancer by noninvasive imagingNature Biotechnology, 25
-
S. Rizzo, F. Botta, S. Raimondi, D. Origgi, V. Buscarino, A. Colarieti, F. Tomao, G. Aletti, V. Zanagnolo, M. Grande, N. Colombo, M. Bellomi (2018)
Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 monthsEuropean Radiology, 28
-
L. Ardighieri, F. Zeppernick, Charlotte Hannibal, R. Vang, L. Cope, J. Junge, S. Kjaer, R. Kurman, I. Shih (2014)
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsThe Journal of Pathology, 232
-
N. Jamshidi, M. Diehn, M. Bredel, M. Kuo (2013)
Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.Radiology, 270 1
-
Shuo Wang, Zhenyu Liu, Yu Rong, Bing Zhou, Yan Bai, Wei Wei, Meiyun Wang, Yingkun Guo, Jie Tian (2019)
Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 132
-
Xiaoli Song, J. Ren, Dan Zhao, Lifang Wang, Honghong Ren, J. Niu (2020)
Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasmsEuropean Radiology, 31
-
Jiangdian Song, Caiyun Yang, L. Fan, Kun Wang, Feng Yang, Shiyuan Liu, Jie Tian (2016)
Lung Lesion Extraction Using a Toboggan Based Growing Automatic Segmentation ApproachIEEE Transactions on Medical Imaging, 35
-
E. Yakirevich, E. Sabo, O. Lavie, S. Mazareb, G. Spagnoli, M. Resnick (2003)
Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 17
-
H. Chan, Ravi Samala, Lubomir Hadjiiski, Chuan Zhou (2020)
Deep Learning in Medical Image Analysis.Advances in experimental medicine and biology, 1213
-
A. Berchuck, E. Iversen, J. Lancaster, J. Pittman, Jingqin Luo, P. Lee, S. Murphy, H. Dressman, P. Febbo, M. West, J. Nevins, J. Marks (2005)
Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian CancersClinical Cancer Research, 11
-
Yann LeCun, Yoshua Bengio, Geoffrey Hinton (2015)
Deep LearningNature, 521
-
Z. Bodalal, S. Trebeschi, T. Nguyen-Kim, W. Schats, R. Beets-Tan (2019)
Radiogenomics: bridging imaging and genomicsAbdominal Radiology, 44
-
Mina Rezaei, Haojin Yang, C. Meinel (2017)
Deep Learning for Medical Image AnalysisArXiv, abs/1708.08987
-
R. Soslow, G. Han, Kay Park, K. Garg, Narciso Olvera, D. Spriggs, N. Kauff, D. Levine (2012)
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinomaModern Pathology, 25
-
S. Nougaret, H. Tibermacine, M. Tardieu, E. Sala (2019)
Radiomics: an Introductory Guide to What It May ForetellCurrent Oncology Reports, 21
-
H. Veeraraghavan, H. Vargas, Alejandro Sanchez, M. Miccò, E. Mema, Y. Lakhman, M. Crispín-Ortuzar, Erich Huang, D. Levine, R. Grisham, N. Abu-Rustum, J. Deasy, A. Snyder, Martin Miller, J. Brenton, E. Sala (2020)
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaCancers, 12
-
H. Vargas, H. Veeraraghavan, M. Miccò, S. Nougaret, Y. Lakhman, A. Meier, Ramon Sosa, R. Soslow, D. Levine, B. Weigelt, C. Aghajanian, H. Hricak, J. Deasy, A. Snyder, E. Sala (2017)
A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcomeEuropean Radiology, 27
-
A. Zwanenburg, M. Vallières, M. Abdalah, H. Aerts, V. Andrearczyk, A. Apte, S. Ashrafinia, S. Bakas, R. Beukinga, R. Boellaard, M. Bogowicz, L. Boldrini, I. Buvat, G. Cook, C. Davatzikos, A. Depeursinge, M. Desseroit, N. Dinapoli, C. Dinh, Sebastian Echegaray, I. Naqa, Andrey Fedorov, R. Gatta, R. Gillies, V. Goh, M. Götz, M. Guckenberger, S. Ha, M. Hatt, Fabian Isensee, P. Lambin, S. Leger, R. Leijenaar, J. Lenkowicz, F. Lippert, Are Losnegård, Klaus Maier-Hein, O. Morin, H. Müller, S. Napel, C. Nioche, Fanny Orlhac, Sarthak Pati, E. Pfaehler, A. Rahmim, Arvind Rao, Jonas Scherer, M. Siddique, N. Sijtsema, Jairo Fernandez, E. Spezi, R. Steenbakkers, S. Tanadini-Lang, D. Thorwarth, E. Troost, T. Upadhaya, V. Valentini, L. Dijk, Joost Griethuysen, F. Velden, P. Whybra, C. Richter, S. Löck (2016)
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.Radiology
-
M. Lubner, Andrew Smith, K. Sandrasegaran, D. Sahani, P. Pickhardt (2017)
CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges.Radiographics : a review publication of the Radiological Society of North America, Inc, 37 5
-
Gang Li, D. Han, Chao Wang, Wenxing Hu, V. Calhoun, Yu-ping Wang (2020)
Application of deep canonically correlated sparse autoencoder for the classification of schizophreniaComputer methods and programs in biomedicine, 183
-
L. Beer, Hilal Şahin, N. Bateman, Ivana Blažić, H. Vargas, H. Veeraraghavan, J. Kirby, Brenda Fevrier-Sullivan, J. Freymann, C. Jaffe, J. Brenton, M. Miccò, S. Nougaret, K. Darcy, G. Maxwell, T. Conrads, Erich Huang, E. Sala (2020)
Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysisEuropean Radiology, 30
-
Roberto Gullo, Isaac Daimiel, E. Morris, K. Pinker (2020)
Combining molecular and imaging metrics in cancer: radiogenomicsInsights into Imaging, 11
-
Ken Chang, N. Balachandar, Carson Lam, Darvin Yi, James Brown, Andrew Beers, B. Rosen, D. Rubin, Jayashree Kalpathy-Cramer (2018)
Distributed deep learning networks among institutions for medical imagingJournal of the American Medical Informatics Association : JAMIA, 25
-
Yi Cui, S. Ren, K. Tha, Jia Wu, H. Shirato, Ruijiang Li (2017)
Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastomaEuropean Radiology, 27
-
M. Diehn, C. Nardini, David Wang, S. McGovern, M. Jayaraman, Yu Liang, K. Aldape, S. Cha, M. Kuo (2008)
Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesProceedings of the National Academy of Sciences, 105
-
J. Welsh, P. Zarrinkar, L. Sapinoso, S. Kern, C. Behling, B. Monk, D. Lockhart, R. Burger, G. Hampton (2001)
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.Proceedings of the National Academy of Sciences of the United States of America, 98 3
-
C. Langlotz, Bibb Allen, B. Erickson, Jayashree Kalpathy-Cramer, K. Bigelow, T. Cook, A. Flanders, M. Lungren, David Mendelson, J. Rudie, Ge Wang, K. Kandarpa (2019)
A Roadmap for Foundational Research on Artificial Intelligence in Medical Imaging: From the 2018 NIH/RSNA/ACR/The Academy Workshop.Radiology, 291 3
-
P. Lambin, Emmanuel Rios-Velazquez, R. Leijenaar, S. Carvalho, R. Stiphout, P. Granton, C. Zegers, R. Gillies, R. Boellard, A. Dekker, H. Aerts (2012)
Radiomics: extracting more information from medical images using advanced feature analysis.European journal of cancer, 48 4
-
D. Etemadmoghadam, A. deFazio, R. Beroukhim, C. Mermel, J. George, G. Getz, R. Tothill, A. Okamoto, M. Raeder, P. Harnett, S. Lade, L. Akslen, A. Tinker, Bianca Locandro, K. Alsop, Y. Chiew, N. Traficante, S. Fereday, Daryl Johnson, S. Fox, W. Sellers, M. Urashima, H. Salvesen, M. Meyerson, D. Bowtell (2009)
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian CarcinomasClinical Cancer Research, 15
-
A. Cottereau, H. Lanic, S. Mareschal, M. Meignan, P. Vera, H. Tilly, F. Jardin, S. Becker (2015)
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell LymphomaClinical Cancer Research, 22
-
A. Patch, E. Christie, D. Etemadmoghadam, D. Garsed, J. George, S. Fereday, K. Nones, P. Cowin, K. Alsop, Peter Bailey, K. Kassahn, F. Newell, M. Quinn, S. Kazakoff, Kelly Quek, C. Wilhelm-Benartzi, E. Curry, H. Leong, A. Hamilton, L. Mileshkin, G. Au-Yeung, C. Kennedy, J. Hung, Y. Chiew, P. Harnett, M. Friedlander, M. Quinn, J. Pyman, S. Cordner, Patricia O’Brien, Jodie Leditschke, Greg Young, Kate Strachan, P. Waring, Walid Azar, C. Mitchell, N. Traficante, J. Hendley, Heather Thorne, M. Shackleton, David Miller, Gisela Arnau, R. Tothill, Timothy Holloway, T. Semple, Ivon Harliwong, C. Nourse, Ehsan Nourbakhsh, Suzanne Manning, S. Idrisoglu, T. Bruxner, Angelika Christ, B. Poudel, O. Holmes, M. Anderson, C. Leonard, A. Lonie, N. Hall, S. Wood, Darrin Taylor, Qinying Xu, J. Fink, N. Waddell, R. Drapkin, E. Stronach, H. Gabra, Robert Brown, A. Jewell, Shivashankar Nagaraj, Emma Markham, P. Wilson, J. Ellul, O. Mcnally, M. Doyle, R. Vedururu, C. Stewart, E. Lengyel, J. Pearson, N. Waddell, A. deFazio, S. Grimmond, D. Bowtell (2015)
Whole–genome characterization of chemoresistant ovarian cancerNature, 521
-
Kelly Bolton, G. Chenevix-Trench, Cindy Goh, S. Sadetzki, S. Ramus, B. Karlan, D. Lambrechts, E. Despierre, D. Barrowdale, L. McGuffog, S. Healey, D. Easton, O. Sinilnikova, Javier Benítez, M. García, S. Neuhausen, Mitchell Gail, P. Hartge, S. Peock, D. Frost, D. Evans, R. Eeles, Andrew Godwin, M. Daly, A. Kwong, Edmond Ma, C. Lázaro, Ignacio Blanco, M. Montagna, E. D'andrea, M. Nicoletto, S. Johnatty, S. Kjær, Allan Jensen, E. Høgdall, E. Goode, B. Fridley, J. Loud, Mark Greene, P. Mai, Angela Chetrit, F. Lubin, G. Hirsh-Yechezkel, G. Glendon, I. Andrulis, A. Toland, L. Senter, Martin Gore, C. Gourley, C. Michie, Honglin Song, J. Tyrer, A. Whittemore, Valerie McGuire, W. Sieh, Ulf Kristoffersson, Håkan Olsson, Åke Borg, D. Levine, L. Steele, Mary Beattie, Salina Chan, Robert Nussbaum, K. Moysich, J. Gross, I. Cass, Christine Walsh, A. Li, R. Leuchter, O. Gordon, M. García-Closas, S. Gayther, S. Chanock, A. Antoniou, Paul Pharoah (2012)
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.JAMA, 307 4
-
H. Bai, Ashley Lee, Li Yang, Paul Zhang, C. Davatzikos, J. Maris, S. Diskin (2016)
Imaging genomics in cancer research: limitations and promises.The British journal of radiology, 89 1061
-
Shota Yamamoto, Danshan Huang, Liutao Du, R. Korn, N. Jamshidi, B. Burnette, M. Kuo (2016)
Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.Radiology, 280 1
-
Xing Hao, Guigang Zhang, Shang Ma (2016)
Deep LearningInt. J. Semantic Comput., 10
-
Meiqin Gong, Siyu Chen, Qingyuan Chen, Yuanqi Zeng, Yongqing Zhang (2020)
Generative Adversarial Networks in Medical Image Processing.Current pharmaceutical design
-
Darcie Delzell, Sara Magnuson, Tabitha Peter, M. Smith, Brian Smith (2019)
Machine Learning and Feature Selection Methods for Disease Classification With Application to Lung Cancer Screening Image DataFrontiers in Oncology, 9
-
Micah Sheller, G. Reina, Brandon Edwards, Jason Martin, S. Bakas (2018)
Multi-Institutional Deep Learning Modeling Without Sharing Patient Data: A Feasibility Study on Brain Tumor SegmentationBrainlesion : glioma, multiple sclerosis, stroke and traumatic brain injuries : second International Workshop, BrainLes 2016, with the challenges on BRATS, ISLES and mTOP 2016, held in conjunction with MICCAI 2016, Athens, Greece, Octob..., 11383
-
P. Lambin, R. Stiphout, M. Starmans, Emmanuel Rios-Velazquez, G. Nalbantov, H. Aerts, E. Roelofs, W. Elmpt, P. Boutros, P. Granone, V. Valentini, A. Begg, D. Ruysscher, A. Dekker (2013)
Predicting outcomes in radiation oncology—multifactorial decision support systemsNature Reviews Clinical Oncology, 10
-
V. Mandilaras, S. Garg, M. Cabanero, Qian Tan, C. Pastrello, Julie Burnier, K. Karakasis, Lisa Wang, N. Dhani, M. Butler, Philippe Bédard, L. Siu, B. Clarke, P. Shaw, T. Stockley, I. Jurisica, A. Oza, S. Lheureux (2019)
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analysesInternational Journal of Gynecologic Cancer, 29
-
P. Martin-Gonzalez, M. Crispín-Ortuzar, L. Rundo, M. Delgado-Ortet, M. Reinius, L. Beer, R. Woitek, Stephan Ursprung, H. Addley, J. Brenton, F. Markowetz, E. Sala (2020)
Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancerInsights into Imaging, 11
-
J. Farley, Leia Smith, K. Darcy, E. Sobel, D. O'connor, B. Henderson, L. Morrison, M. Birrer (2003)
Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.Cancer research, 63 6
-
S. Rizzo, L. Manganaro, M. Dolciami, M. Gasparri, A. Papadia, F. Grande (2021)
Computed Tomography Based Radiomics as a Predictor of Survival in Ovarian Cancer Patients: A Systematic ReviewCancers, 13
-
Y. Qiu, Maxine Tan, S. McMeekin, T. Thai, K. Ding, K. Moore, Hong Liu, B. Zheng (2016)
Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysisActa Radiologica, 57
-
M. Gerlinger, A. Rowan, S. Horswell, M. Math, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, Sharmin Begum, N. McDonald, A. Butler, David Jones, K. Raine, Calli Latimer, Claudio Santos, M. Nohadani, A. Eklund, B. Spencer‐Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P. Futreal, C. Swanton (2012)
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.The New England journal of medicine, 366 10
-
Daniel Kermany, Daniel Kermany, M. Goldbaum, Wenjia Cai, C. Valentim, Huiying Liang, Sally Baxter, A. McKeown, Ge Yang, Xiaokang Wu, Fangbing Yan, J. Dong, Made Prasadha, Jacqueline Pei, Jacqueline Pei, M. Ting, Jie Zhu, Christina Li, Sierra Hewett, Sierra Hewett, Jason Dong, Ian Ziyar, Alexander Shi, Runze Zhang, Lianghong Zheng, Rui Hou, W. Shi, Xin Fu, Xin Fu, Yaou Duan, V. Huu, V. Huu, Cindy Wen, Edward Zhang, Edward Zhang, Charlotte Zhang, Charlotte Zhang, Oulan Li, Oulan Li, Xiaobo Wang, M. Singer, Xiaodong Sun, Jie Xu, A. Tafreshi, M. Lewis, H. Xia, Kang Zhang (2018)
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep LearningCell, 172
-
K. Wong, Y. Tsang, M. Deavers, S. Mok, Z. Zu, Charlotte Sun, A. Malpica, J. Wolf, K. Lu, D. Gershenson (2010)
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.The American journal of pathology, 177 4
-
G. Singer, Robert Oldt, Y. Cohen, Brant Wang, D. Sidransky, R. Kurman, I. Shih (2003)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.Journal of the National Cancer Institute, 95 6
-
D. Schwartz, S. Kardia, K. Shedden, R. Kuick, G. Michailidis, Jeremy Taylor, David Misek, R. Wu, Y. Zhai, Danielle Darrah, Heather Reed, L. Ellenson, T. Giordano, E. Fearon, S. Hanash, Kathleen Cho (2002)
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.Cancer research, 62 16
-
Improved survival for BRCA 2 - associated serous ovarian -
Anis Kaldawy, Y. Segev, O. Lavie, R. Auslender, V. Sopik, S. Narod (2016)
Low-grade serous ovarian cancer: A review.Gynecologic oncology, 143 2
-
A. Kazerooni, M. Malek, H. Haghighatkhah, Sara Parviz, Mahnaz Nabil, Leila Torbati, S. Assili, H. Rad, M. Gity (2017)
Semiquantitative dynamic contrast‐enhanced MRI for accurate classification of complex adnexal massesJournal of Magnetic Resonance Imaging, 45
-
Sue Cao, Linqi Zhang, Sichi Kuang, Wenqi Shi, Bing Hu, Sidong Xie, Yi-nan Chen, Hui Liu, Silu Chen, T. Jiang, M. Ye, Hanxi Zhang, Jin Wang (2020)
Multiphase convolutional dense network for the classification of focal liver lesions on dynamic contrast-enhanced computed tomographyWorld Journal of Gastroenterology, 26
-
A. Bashashati, G. Ha, A. Tone, Jiarui Ding, Leah Prentice, Andrew Roth, Jamie Rosner, K. Shumansky, S. Kalloger, J. Senz, Winnie Yang, M. Mcconechy, Nataliya Melnyk, M. Anglesio, M. Luk, Kane Tse, Thomas Zeng, Richard Moore, Yongjun Zhao, M. Marra, B. Gilks, S. Yip, D. Huntsman, J. McAlpine, Sohrab Shah (2013)
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingThe Journal of Pathology, 231
-
R. Siegel, K. Miller, A. Jemal (2020)
Cancer statistics, 2020CA: A Cancer Journal for Clinicians, 70
-
B. Weigelt, H. Vargas, P. Selenica, F. Geyer, Y. Mazaheri, P. Blecua, N. Conlon, L. Hoang, A. Jungbluth, A. Snyder, C. Ng, A. Papanastasiou, Ramon Sosa, R. Soslow, D. Chi, G. Gardner, R. Shen, J. Reis-Filho, E. Sala (2019)
Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer.JCO precision oncology, 3
-
M. Götz, M. Nolden, Klaus Maier-Hein (2019)
MITK Phenotyping: An open-source toolchain for image-based personalized medicine with radiomics.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 131
-
Guangxing Wang, Yang Sun, Youting Chen, Qiqi Gao, Dongqing Peng, Hongxin Lin, Z. Zhan, Zhiyi Liu, S. Zhuo (2020)
Rapid identification of human ovarian cancer in second harmonic generation images using radiomics feature analyses and tree‐based pipeline optimization toolJournal of Biophotonics, 13
-
S. Nougaret, Y. Lakhman, M. Gönen, D. Goldman, M. Miccò, M. D’Anastasi, Sarah Johnson, K. Juluru, A. Arnold, Ramon Sosa, R. Soslow, H. Vargas, H. Hricak, N. Kauff, E. Sala (2017)
High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.Radiology, 285 2
-
Alison Karst, P. Jones, Natalie Vena, A. Ligon, Joyce Liu, M. Hirsch, D. Etemadmoghadam, D. Bowtell, R. Drapkin (2014)
Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.Cancer research, 74 4
-
C. Gilks, B. Vanderhyden, Shirley Zhu, M. Rijn, T. Longacre (2005)
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.Gynecologic oncology, 96 3
-
Junming Jian, Yong'ai Li, P. Pickhardt, W. Xia, Zhang He, Rui Zhang, S. Zhao, Xingyu Zhao, S. Cai, Jiayi Zhang, Guofu Zhang, Jingxuan Jiang, Yan Zhang, Keying Wang, G. Lin, F. Feng, Xiaodong Wu, Xin Gao, J. Qiang (2020)
MR image-based radiomics to differentiate type Ι and type ΙΙ epithelial ovarian cancersEuropean Radiology, 31
-
P. Grossmann, O. Stringfield, N. El-Hachem, M. Bui, E. Velazquez, C. Parmar, R. Leijenaar, B. Haibe-Kains, P. Lambin, R. Gillies, H. Aerts (2017)
Defining the biological basis of radiomic phenotypes in lung cancereLife, 6
-
H. Vargas, Erich Huang, Y. Lakhman, Joseph Ippolito, P. Bhosale, V. Mellnick, A. Shinagare, Maria Anello, J. Kirby, Brenda Fevrier-Sullivan, J. Freymann, C. Jaffe, E. Sala (2017)
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.Radiology, 285 2
-
D. Bell, A. Berchuck, M. Birrer, J. Chien, D. Cramer, F. Dao, R. Dhir, P. Disaia, H. Gabra, Pat Glenn, A. Godwin, J. Gross, L. Hartmann, M. Huang, D. Huntsman, M. Iacocca, M. Imieliński, S. Kalloger, B. Karlan, D. Levine, G. Mills, C. Morrison, D. Mutch, Narciso Olvera, S. Orsulic, K. Park, N. Petrelli, B. Rabeno, J. Rader, B. Sikic, K. Smith-McCune, A. Sood, D. Bowtell, R. Penny, J. Testa, K. Chang, H. Dinh, J. Drummond, G. Fowler, P. Gunaratne, A. Hawes, C. Kovar, L. Lewis, M. Morgan, I. Newsham, J. Santibanez, J. Reid, L. Treviño, Y. Wu, M. Wang, D. Muzny, D. Wheeler, R. Gibbs, G. Getz, M. Lawrence, K. Cibulskis, A. Sivachenko, C. Sougnez, Douglas Voet, Jane Wilkinson, Toby Bloom, K. Ardlie, T. Fennell, J. Baldwin, S. Gabriel, E. Lander, L. Ding, R. Fulton, D. Koboldt, M. McLellan, T. Wylie, Jason Walker, M. O'Laughlin, D. Dooling, L. Fulton, R. Abbott, N. Dees, Q. Zhang, C. Kandoth, M. Wendl, W. Schierding, D. Shen, C. Harris, H. Schmidt, Joelle Kalicki, K. Delehaunty, C. Fronick, Ryan Demeter, L. Cook, J. Wallis, L. Lin, V. Magrini, J. Hodges, James Eldred, S. Smith, C. Pohl, Fabio Vandin, Benjamin Raphael, G. Weinstock, E. Mardis, R. Wilson, M. Meyerson, W. Winckler, R. Verhaak, Suzie Carter, C. Mermel, G. Saksena, H. Nguyen, R. Onofrio, D. Hubbard, S. Gupta, A. Crenshaw, A. Ramos, L. Chin, A. Protopopov, Juinhua Zhang, T. Kim, I. Perna, Y. Xiao, Hailei Zhang, G. Ren, N. Sathiamoorthy, R. Park, E. Lee, P. Park, R. Kucherlapati, D. Absher, L. Waite, G. Sherlock, J. Brooks, Jun Li, Jin Xu, R. Myers, P. Laird, L. Cope, J. Herman, Hui Shen, D. Weisenberger, H. Noushmehr, F. Pan, T. Triche, B. Berman, D. Berg, J. Buckley, S. Baylin, P. Spellman, E. Purdom, P. Neuvial, H. Bengtsson, L. Jakkula, S. Durinck, J. Han, S. Dorton, H. Marr, Y. Choi, V. Wang, Ninghai Wang, J. Ngai, J. Conboy, B. Parvin, H. Feiler, T. Speed, J. Gray, N. Socci, Yanke Liang, B. Taylor, N. Schultz, L. Borsu, A. Lash, C. Brennan, A. Viale, C. Sander, M. Ladanyi, K. Hoadley, S. Meng, Y. Du, Yufeng Shi, Lulin Li, Y. Turman, D. Zang, E. Helms, S. Balu, X. Zhou, Jinhua Wu, M. Topal, D. Hayes, C. Perou, Jun Zhang, Chaowei Wu, S. Shukla, A. Sivachenko, R. Jing, Yueh-Feng Liu, M. Noble, H. Carter, D. Kim, R. Karchin, J. Korkola, Laura Heiser, R. Cho, Zhihao Hu, E. Cerami, A. Olshen, B. Reva, Yevgeniy Antipin, R. Shen, P. Mankoo, R. Sheridan, G. Ciriello, William Chang, J. Bernanke, D. Haussler, C. Benz, Joshua Stuart, S. Benz, J. Sanborn, Charles Vaske, Jiangyu Zhu, C. Szeto, G. Scott, C. Yau, M. Wilkerson, N. Zhang, R. Akbani, K. Baggerly, W. Yung, J. Weinstein, T. Shelton, D. Grimm, M. Hatfield, S. Morris, P. Yena, P. Rhodes, M. Sherman, J. Paulauskis, S. Millis, A. Kahn, J. Greene, R. Sfeir, M. Jensen, James Chen, J. Whitmore, S. Alonso, J. Jordan, A. Chu, Jinghui Zhang, A. Barker, C. Compton, G. Eley, M. Ferguson, P. Fielding, D. Gerhard, R. Myles, C. Schaefer, K. Shaw, J. Vaught, J. Vockley, P. Good, M. Guyer, B. Ozenberger, James Peterson, E. Thomson (2011)
Integrated Genomic Analyses of Ovarian CarcinomaNature, 474
-
R. Grisham, G. Iyer, K. Garg, D. DeLair, D. Hyman, Qin Zhou, A. Iasonos, M. Berger, F. Dao, D. Spriggs, D. Levine, C. Aghajanian, D. Solit (2013)
BRAF Mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancerCancer, 119
-
A. Ashraf, D. Daye, S. Gavenonis, C. Mies, M. Feldman, M. Rosen, D. Kontos (2014)
Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.Radiology, 272 2
-
J. Ledermann, P. Harter, C. Gourley, M. Friedlander, I. Vergote, G. Rustin, C. Scott, W. Meier, R. Shapira-Frommer, T. Safra, D. Matei, E. Macpherson, C. Watkins, J. Carmichael, U. Matulonis (2012)
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.The New England journal of medicine, 366 15
-
S. Cooke, C. Ng, Nataliya Melnyk, M. García, Thomas Hardcastle, Jillian Temple, S. Langdon, D. Huntsman, J. Brenton (2010)
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinomaOncogene, 29
-
Da Yang, Sofia Khan, Yan Sun, K. Hess, I. Shmulevich, A. Sood, Wei Zhang (2011)
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.JAMA, 306 14
-
Hui Li, Yitan Zhu, E. Burnside, K. Drukker, K. Hoadley, C. Fan, S. Conzen, G. Whitman, E. Sutton, J. Net, M. Ganott, Erich Huang, E. Morris, C. Perou, Yuan Ji, M. Giger (2016)
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.Radiology, 281 2
-
Wei Wei, Y. Rong, Zhenyu Liu, Bin Zhou, Zhenchao Tang, Shuo Wang, D. Dong, Yali Zang, Yingkun Guo (2018)
Radiomics: a Novel CT-Based Method of Predicting Postoperative Recurrence in Ovarian Cancer2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
-
Y. Fung, K. Ng, Simon Vogrin, Catherine Meade, Michael Ngo, S. Collins, S. Bowden (2019)
Comparative Utility of Manual versus Automated Segmentation of Hippocampus and Entorhinal Cortex Volumes in a Memory Clinic Sample.Journal of Alzheimer's disease : JAD, 68 1
-
S. Nougaret, Y. Lakhman, N. Molinari, D. Feier, C. Scelzo, H. Vargas, Ramon Sosa, H. Hricak, R. Soslow, R. Grisham, E. Sala (2018)
CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.AJR. American journal of roentgenology, 210 4
-
Chiharu Kai, Y. Uchiyama, J. Shiraishi, H. Fujita, K. Doi (2018)
Computer-aided diagnosis with radiogenomics: analysis of the relationship between genotype and morphological changes of the brain magnetic resonance imagesRadiological Physics and Technology, 11
-
X. Meng, W. Xia, P. Xie, Rui Zhang, Wenru Li, Mengmeng Wang, F. Xiong, Yangchuan Liu, Xinjuan Fan, Yao Xie, X. Wan, K. Zhu, H. Shan, Lei Wang, Xin Gao (2018)
Preoperative radiomic signature based on multiparametric magnetic resonance imaging for noninvasive evaluation of biological characteristics in rectal cancerEuropean Radiology, 29
-
R. Verhaak, P. Tamayo, Ji-Yeon Yang, D. Hubbard, Hailei Zhang, C. Creighton, S. Fereday, M. Lawrence, S. Carter, C. Mermel, A. Kostic, D. Etemadmoghadam, G. Saksena, K. Cibulskis, S. Duraisamy, Keren Levanon, C. Sougnez, Aviad Tsherniak, Sebastian Gomez, R. Onofrio, S. Gabriel, L. Chin, Nianxiang Zhang, P. Spellman, Yiqun Zhang, R. Akbani, K. Hoadley, A. Kahn, M. Köbel, D. Huntsman, R. Soslow, A. deFazio, M. Birrer, J. Gray, J. Weinstein, D. Bowtell, R. Drapkin, J. Mesirov, G. Getz, D. Levine, M. Meyerson (2012)
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.The Journal of clinical investigation, 123 1
-
P. Lambin, R. Leijenaar, T. Deist, J. Peerlings, E. Jong, J. Timmeren, S. Sanduleanu, R. Larue, A. Even, A. Jochems, Y. Wijk, H. Woodruff, J. Soest, T. Lustberg, E. Roelofs, W. Elmpt, A. Dekker, F. Mottaghy, J. Wildberger, S. Walsh (2017)
Radiomics: the bridge between medical imaging and personalized medicineNature Reviews Clinical Oncology, 14
-
Haonan Lu, M. Arshad, A. Thornton, Giacomo Avesani, P. Cunnea, E. Curry, F. Kanavati, Jackson Liang, K. Nixon, Sophie Williams, Mona Hassan, D. Bowtell, H. Gabra, C. Fotopoulou, A. Rockall, E. Aboagye (2019)
A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancerNature Communications, 10
-
Lingli Li, X. Kan, Yong-kai Zhao, Bo Liang, Tianhe Ye, Lian Yang, C. Zheng (2021)
Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular CarcinomaInternational Journal of Medical Sciences, 18
-
J. Staub, J. Chien, Y. Pan, X. Qian, K. Narita, G. Aletti, M. Scheerer, L. Roberts, J. Molina, V. Shridhar (2007)
Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistanceOncogene, 26
-
R. Conti, D. Veenstra, K. Armstrong, L. Lesko, S. Grosse (2010)
Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research PrioritiesMedical Decision Making, 30
-
A. Meier, H. Veeraraghavan, S. Nougaret, Y. Lakhman, Ramon Sosa, R. Soslow, E. Sutton, H. Hricak, E. Sala, H. Vargas (2018)
Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancerAbdominal Radiology, 44
-
Xiaoxuan Liu, L. Faes, A. Kale, S. Wagner, D. Fu, A. Bruynseels, T. Mahendiran, Gabriella Moraes, Mohith Shamdas, C. Kern, J. Ledsam, M. Schmid, K. Balaskas, E. Topol, L. Bachmann, P. Keane, A. Denniston (2019)
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis.The Lancet. Digital health, 1 6
-
D. Hyman, Qin Zhou, A. Iasonos, R. Grisham, A. Arnold, M. Phillips, J. Bhatia, D. Levine, C. Aghajanian, K. Offit, R. Barakat, D. Spriggs, N. Kauff (2012)
Improved survival for BRCA2‐associated serous ovarian cancer compared with both BRCA‐negative and BRCA1‐associated serous ovarian cancerCancer, 118
-
M. Matz, M. Coleman, H. Carreira, D. Salmerón, M. Chirlaque, C. Allemani (2017)
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).Gynecologic oncology, 144 2
-
H. Vargas, M. Miccò, S. Hong, D. Goldman, F. Dao, B. Weigelt, R. Soslow, H. Hricak, D. Levine, E. Sala (2015)
Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.Radiology, 274 3
-
R. Kurman, I. Shih (2016)
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.The American journal of pathology, 186 4
-
Jia Wu, Xiaoli Sun, Jeff Wang, Yi Cui, F. Kato, H. Shirato, D. Ikeda, Ruijiang Li (2017)
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validationJournal of Magnetic Resonance Imaging, 46
-
Nuo Tong, S. Gou, T. Niu, Shuyuan Yang, K. Sheng (2020)
Self-paced DenseNet with boundary constraint for automated multi-organ segmentation on abdominal CT imagesPhysics in Medicine & Biology, 65
-
M. Koutsaki, A. Zaravinos, D. Spandidos (2012)
Modern Trends into the Epidemiology and Screening of Ovarian Cancer. Genetic Substrate of the Sporadic FormPathology & Oncology Research, 18
-
Gopichandh Danala, T. Thai, C. Gunderson, K. Moxley, K. Moore, R. Mannel, Hong Liu, B. Zheng, Y. Qiu (2017)
Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy.Academic radiology, 24 10
-
M Reyes, Angela Arnold, N. Kauff, Douglas Levine, R. Soslow (2014)
Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiencyModern Pathology, 27
-
H. Aerts, E. Velazquez, R. Leijenaar, C. Parmar, P. Grossmann, Sara Cavalho, J. Bussink, R. Monshouwer, Benjamin Haibe-Kains, D. Rietveld, F. Hoebers, M. Rietbergen, C. Leemans, A. Dekker, John Quackenbush, R. Gillies, P. Lambin (2014)
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachNature Communications, 5
-
F. Arezzo, V. Loizzi, D. Forgia, M. Moschetta, A. Tagliafico, V. Cataldo, Adam Kawosha, Vincenzo Venerito, Gerardo Cazzato, G. Ingravallo, L. Resta, E. Cicinelli, G. Cormio (2021)
Radiomics Analysis in Ovarian Cancer: A Narrative ReviewApplied Sciences
-
T. Bonome, Ji-Young Lee, D. Park, M. Radonovich, C. Pise-Masison, J. Brady, G. Gardner, Ke Hao, Wing Wong, J. Barrett, K. Lu, A. Sood, D. Gershenson, S. Mok, M. Birrer (2005)
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.Cancer research, 65 22
-
Chan Han, Yu-jing Huang, K. Lu, Zhensheng Liu, G. Mills, Q. Wei, Li‐E. Wang (2011)
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancerJournal of Experimental & Clinical Cancer Research : CR, 30
-
L. Khalique, Ayse Ayhan, Michael Weale, Ian Jacobs, S. Ramus, S. Gayther (2007)
Genetic intra‐tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumoursThe Journal of Pathology, 211
-
T. Vokes, A. Pham, J. Wilkie, M. Kocherginsky, Siu-Ling Ma, M. Chinander, T. Karrison, Octavia Bris, M. Giger (2008)
Reproducibility and sources of variability in radiographic texture analysis of densitometric calcaneal images.Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 11 2
-
E. Roelofs, A. Dekker, E. Meldolesi, R. Stiphout, V. Valentini, P. Lambin (2014)
International data-sharing for radiotherapy research: an open-source based infrastructure for multicentric clinical data mining.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 110 2
-
H. Kawagoe, A. Yamada, H. Matsumoto, M. Ito, K. Ushijima, T. Nishida, M. Yakushiji, K. Itoh (2000)
Serum MAGE-4 protein in ovarian cancer patients.Gynecologic oncology, 76 3
-
Shuo Wang, Mu Zhou, Zaiyi Liu, Zhenyu Liu, D. Gu, Yali Zang, D. Dong, O. Gevaert, Jie Tian (2017)
Central focused convolutional neural networks: Developing a data-driven model for lung nodule segmentationMedical image analysis, 40
-
L. Hartmann, K. Lu, G. Linette, W. Cliby, K. Kalli, D. Gershenson, R. Bast, J. Stec, N. Iartchouk, David Smith, J. Ross, S. Hoersch, V. Shridhar, J. Lillie, S. Kaufmann, E. Clark, A. Damokosh (2005)
Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel ChemotherapyClinical Cancer Research, 11
-
R. Forstner, E. Sala, K. Kinkel, J. Spencer (2010)
ESUR guidelines: ovarian cancer staging and follow-upEuropean Radiology, 20
-
F. Coscia, K. Watters, M. Curtis, Mark Eckert, Chun-Yi Chiang, Stefka Tyanova, A. Montag, R. Lastra, E. Lengyel, M. Mann (2016)
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional statusNature Communications, 7
-
R. Soslow (2008)
Histologic subtypes of ovarian carcinoma: an overview.International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 27 2
-
S. Nougaret, C. McCague, H. Tibermacine, H. Vargas, S. Rizzo, Evis Sala (2020)
Radiomics and radiogenomics in ovarian cancer: a literature reviewAbdominal Radiology, 46
-
D. Spentzos, D. Levine, M. Ramoni, Marie Joseph, Xuesong Gu, J. Boyd, T. Libermann, S. Cannistra (2004)
Gene expression signature with independent prognostic significance in epithelial ovarian cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 23
-
Qianying Ouyang, Yujie Liu, Jieqiong Tan, Jie Li, Dawei Yang, F. Zeng, Weihua Huang, Y. Kong, Zhaoqian Liu, Honghao Zhou, Yingzi Liu (2019)
Loss of ZNF587B and SULF1 contributed to cisplatin resistance in ovarian cancer cell lines based on Genome-scale CRISPR/Cas9 screening.American journal of cancer research, 9 5
-
L. Qian, J. Ren, Aishi Liu, Yang Gao, Fene Hao, Lei Zhao, Hui Wu, G. Niu (2020)
MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypesEuropean Radiology, 30
-
L. Ding, M. Wendl, D. Koboldt, E. Mardis (2010)
Analysis of next-generation genomic data in cancer: accomplishments and challenges.Human molecular genetics, 19 R2
-
R. Schwarz, C. Ng, S. Cooke, S. Newman, Jillian Temple, A. Piskorz, D. Gale, K. Sayal, M. Murtaza, P. Baldwin, N. Rosenfeld, H. Earl, E. Sala, M. Jimenez-Linan, C. Parkinson, F. Markowetz, J. Brenton (2015)
Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic AnalysisPLoS Medicine, 12
-
M. Karim, K. Ohta, M. Egashira, Y. Jinno, N. Niikawa, I. Matsuda, Y. Indo (1996)
Human ESP1/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3.Genomics, 31 2
-
S. Sarrazin, William Lamanna, J. Esko (2011)
Heparan sulfate proteoglycans.Cold Spring Harbor perspectives in biology, 3 7
-
Yanqi Huang, C. Liang, Lan He, Jie Tian, Cuishan Liang, Xin Chen, Zelan Ma, Zai-Yi Liu (2016)
Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 18
-
S. Armato, Geoffrey Mclennan, Luc Bidaut, M. McNitt-Gray, C. Meyer, Anthony Reeves, Binsheng Zhao, Denise Aberle, C. Henschke, Eric Hoffman, Ella Kazerooni, H. MacMahon, Edwin Beek, David Yankelevitz, Alberto Biancardi, P. Bland, Matthew Brown, R. Engelmann, Gary Laderach, Daniel Max, Richard Pais, David Qing, R. Roberts, Amanda Smith, A. Starkey, Poonam Batra, P. Caligiuri, Ali Farooqi, G. Gladish, C. Jude, R. Munden, I. Petkovska, L Quint, Lawrence Schwartz, B. Sundaram, Lori Dodd, C. Fenimore, David Gur, Nicholas Petrick, J. Freymann, Justin Kirby, Brian Hughes, Alessi Casteele, Sangeeta Gupte, Maha Sallam, Michael Heath, Michael Kuhn, E. Dharaiya, Richard Burns, David Fryd, M. Salganicoff, V. Anand, U. Shreter, S. Vastagh, Barbara Croft, Laurence Clarke (2011)
The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans.Medical physics, 38 2
-
K. Nie, Liming Shi, Qin Chen, Xi Hu, S. Jabbour, N. Yue, T. Niu, Xiaonan Sun (2016)
Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRIClinical Cancer Research, 22
-
Xiaoping He, A. Khurana, D. Roy, S. Kaufmann, V. Shridhar (2014)
Loss of HSulf‐1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancerInternational Journal of Cancer, 135
-
H. Farmer, N. Mccabe, C. Lord, A. Tutt, Damian Johnson, T. Richardson, M. Santarosa, Krystyna Dillon, I. Hickson, C. Knights, N. Martin, S. Jackson, G. Smith, A. Ashworth (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 434
-
International Consortium (2001)
Initial sequencing and analysis of the human genomeNature, 409
-
K. Shin, W. Yang (2015)
Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression ProfilesBreast Diseases: A Year Book Quarterly, 26
-
D. Etemadmoghadam, J. George, P. Cowin, C. Cullinane, Maya Kansara, Kylie Gorringe, G. Smyth, D. Bowtell (2010)
Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian CancerPLoS ONE, 5
-
A. Cheung, J. Ko, H. Lung, K. Chan, E. Stanbridge, E. Zabarovsky, T. Tokino, Lisa Kashima, Toshiharu Suzuki, D. Kwong, D. Chua, S. Tsao, M. Lung (2011)
Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-κB–mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesisProceedings of the National Academy of Sciences, 108
-
Joyce Liu, M. Cristea, P. Frankel, S. Neuhausen, L. Steele, V. Engelstaedter, U. Matulonis, S. Sand, N. Tung, J. Garber, J. Weitzel (2012)
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival.Cancer genetics, 205 1-2
-
R. Weinshilboum, Liewei Wang (2017)
Pharmacogenomics: Precision Medicine and Drug ResponseMayo Clinic Proceedings, 92
-
N. Nakayama, K. Nakayama, Yeasmin Shamima, M. Ishikawa, A. Katagiri, K. Iida, Khoji Miyazaki (2010)
Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancerCancer, 116
-
E. Stover, P. Konstantinopoulos, U. Matulonis, E. Swisher (2016)
Biomarkers of Response and Resistance to DNA Repair Targeted TherapiesClinical Cancer Research, 22
-
Dong-Joo Cheon, A. Walts, Jessica Beach, J. Lester, J. Bomalaski, C. Walsh, W. Wiedemeyer, B. Karlan, S. Orsulic (2014)
Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomasThe Journal of Pathology: Clinical Research, 1
-
M. Kuo, N. Jamshidi (2014)
Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations.Radiology, 270 2
-
M. Kuo, J. Gollub, C. Sirlin, C. Ooi, Xin Chen (2007)
Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.Journal of vascular and interventional radiology : JVIR, 18 7
-
H. Dressman, A. Berchuck, G. Chan, J. Zhai, A. Bild, R. Sayer, J. Cragun, Jennifer Clarke, R. Whitaker, Lihua Li, J. Gray, J. Marks, G. Ginsburg, A. Potti, M. West, J. Nevins, J. Lancaster (2007)
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 5
-
X. Yi, Yingzi Liu, Bolun Zhou, Wang Xiang, Aojian Deng, Yan Fu, Yuanzhe Zhao, Qianying Ouyang, Yujie Liu, Zeen Sun, Keqiang Zhang, Xi Li, F. Zeng, Honghao Zhou, Bihong Chen (2020)
Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 133
-
He Zhang, Y. Mao, Xiaojun Chen, Guoqing Wu, Xuefen Liu, Peng Zhang, Y. Bai, Pengcong Lu, Weigen Yao, Yuanyuan Wang, Jinhua Yu, Guofu Zhang (2019)
Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary studyEuropean Radiology, 29
-
Xin Yi, Ekta Walia, P. Babyn (2018)
Generative Adversarial Network in Medical Imaging: A ReviewMedical image analysis, 58
- Publisher
- Wolters Kluwer Health
- Copyright
- Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
- ISSN
- 0363-8715
- eISSN
- 1532-3145
- DOI
- 10.1097/rct.0000000000001279
- Publisher site
- See Article on Publisher Site
Abstract
Abstract A new interdisciplinary approach based on medical imaging phenotypes, gene expression patterns, and clinical parameters, referred to as radiogenomics, has recently been developed for biomarker identification and clinical risk stratification in oncology, including for the assessment of ovarian cancer. Some radiological phenotypes (implant distribution, lymphadenopathy, and texture-derived features) are related to specific genetic landscapes (BRCA, BRAF, SULF1, the Classification of Ovarian Cancer), and integrated models can improve the efficiency for predicting clinical outcomes. The establishment of databases in medical images and gene expression profile with large sample size and the improvement of artificial intelligence algorithm will further promote the application of radiogenomics in ovarian cancer.
Journal
Journal of Computer Assisted Tomography – Wolters Kluwer Health
Published: May 1, 2022